BioMarin Pharmaceutical Inc.
NasdaqGS:BMRN
$ 82.17
$-9.03 (-9.90%)
$ 82.17
$-9.03 (-9.90%)
End-of-day quote: 04/25/2024

BMRN - BioMarin Pharmaceutical Stock Prediction 2025 - 2030

20 years of reliable BioMarin Pharmaceutical stock forecast. The Wall Street analysts predict Outperform for BMRN. See at a glance whether NasdaqGS:BMRN will rise in the future.

$134.04
Forecast 2023
$474.28
Forecast 2025
$721.73
Forecast 2030
Neutral
TopGraphs Quality Ranking
Forecast 2023
$134.04
Forecast 2025
$474.28
Forecast 2030
$721.73
TopGraphs Quality Ranking
Neutral

Company Info

P/E
0.00
Beta
0.32
Price-to-book Ratio
3.13
Market Cap
17.31B
TEV
17.35 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
113.18%
Forecast 2Y
183.08%
Analyst Price Target
$111.56

BioMarin Pharmaceutical Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

BioMarin Pharmaceutical Stock Forecast 2023

$110.00

In the last five quarters, BioMarin Pharmaceutical’s Price Target has fallen from $114.08 to $111.56 - a -2.21% decrease. Fourteen analysts predict that BioMarin Pharmaceutical’s share price will fall in the coming year, reaching $110.00. This would represent a decrease of -1.4%.

33.87%
33.87
Last update: 04/26/2024

Highest Price Target $140.00

Average Price Target $110.00

Lowest Price Target $80.00

BioMarin Pharmaceutical Stock Predictions 2025

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Jan 2025.

In January 2025, analysts believe the stock price will be $374.45. An increase of 355.7% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Feb 2025.

In February 2025, analysts believe the stock price will be $383.53. An increase of 366.75% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Mar 2025.

In March 2025, analysts believe the stock price will be $392.60. An increase of 377.79% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Apr 2025.

In April 2025, analysts believe the stock price will be $401.68. An increase of 388.84% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in May 2025.

In May 2025, analysts believe the stock price will be $410.75. An increase of 399.88% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Jun 2025.

In June 2025, analysts believe the stock price will be $419.83. An increase of 410.92% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Jul 2025.

In July 2025, analysts believe the stock price will be $428.90. An increase of 421.97% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Aug 2025.

In August 2025, analysts believe the stock price will be $437.98. An increase of 433.01% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Sep 2025.

In September 2025, analysts believe the stock price will be $447.05. An increase of 444.06% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Oct 2025.

In October 2025, analysts believe the stock price will be $456.13. An increase of 455.1% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Nov 2025.

In November 2025, analysts believe the stock price will be $465.20. An increase of 466.15% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Dec 2025.

In December 2025, analysts believe the stock price will be $474.28. An increase of 477.19% compared to the previous month's estimate.

BioMarin Pharmaceutical Stock Prediction 2030

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Jan 2030.

In Jan 2030 analysts predict a share price of $706.37. An increase of 759.64% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Feb 2030.

In Feb 2030 analysts predict a share price of $707.77. An increase of 761.34% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Mar 2030.

In Mar 2030 analysts predict a share price of $709.16. An increase of 763.04% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Apr 2030.

In Apr 2030 analysts predict a share price of $710.56. An increase of 764.74% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in May 2030.

In May 2030 analysts predict a share price of $711.95. An increase of 766.44% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Jun 2030.

In Jun 2030 analysts predict a share price of $713.35. An increase of 768.14% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Jul 2030.

In Jul 2030 analysts predict a share price of $714.75. An increase of 769.84% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Aug 2030.

In Aug 2030 analysts predict a share price of $716.14. An increase of 771.54% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Sep 2030.

In Sep 2030 analysts predict a share price of $717.54. An increase of 773.24% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Oct 2030.

In Oct 2030 analysts predict a share price of $718.94. An increase of 774.94% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Nov 2030.

In Nov 2030 analysts predict a share price of $720.33. An increase of 776.64% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Dec 2030.

In Dec 2030 analysts predict a share price of $721.73. An increase of 778.34% compared to today's share price.

P/E
0.00
Beta
0.32
Price-to-book Ratio
3.13
Market Cap
17.31B
TEV
17.35 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
113.18%
Forecast 2Y
183.08%
Analyst Price Target
$111.56

BioMarin Pharmaceutical Analyst Ratings Frequently Asked Questions

Who are the analysts watching BioMarin Pharmaceutical Inc.?

The following analysts have recently covered BioMarin Pharmaceutical:

Baird
Barclays
BofA Global Research
Canaccord Genuity
CFRA Equity Research
Citigroup Inc
Evercore ISI
Goldman Sachs
Guggenheim Securities, LLC
J.P. Morgan
Jefferies LLC
Marktfeld
Morgan Stanley
Morningstar Inc.
Oppenheimer & Co. Inc.
Piper Sandler Companies
RBC Capital Markets
Stifel
Truist Securities
Wedbush Securities Inc.
William Blair & Company L.L.C.
Cantor Fitzgerald & Co.
Baptista Research
BMO Capital Markets Equity Research
Citigroup Inc. Research
Equisights
Leerink Partners LLC
Raymond James & Associates
Sanford C. Bernstein & Co., LLC
Scotiabank Global Banking and Market
TD Cowen
UBS Investment Bank
Wells Fargo Securities, LLC
CGS International
(This information refers to the last 90 days.)

Who are the sell-side analysts watching BioMarin Pharmaceutical Inc.?

The following sell-side analysts have recently covered BioMarin Pharmaceutical:

Wang, Huidong
Meacham, Geoffrey Christopher
Bansal, Mohit
Nadeau, Philip M.
Richter, Salveen Jaswal
Chattopadhyay, Debjit D.
Tewari, Akash
Paraskevopoulos, Michail
Andersen, Karen
Gershell, Leland James
Raymond, Christopher Joseph
Matteis, Paul Andrew
Schwartz, Joseph Patrick
Lugo, Timothy Francis
Issi, Luca
Argyrides, Andreas
Brayer, Olivia Simone
Majumdar, Ishan
Fye, Jessica Macomber
Biliouris, Konstantinos
Ijem, Whitney Glad
Hardy, Sel
Brill Bongero, Danielle Catherine
Lebowitz, David Neil
Talsania, Parth
Clark-Gartner, Gavin
Purohit, Vikram
Pickering, William
Farmer, George
Merle, Eliana Rachel
Allen, Jack Kilgannon
Lee, Joon So
(This information refers to the last 90 days.)